4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Enabling information re-Use by linking clinical REsearch and CAre (EURECA)
Date du début: 1 févr. 2012, Date de fin: 31 juil. 2015,
Description
EURECA (Enabling information re-Use by linking clinical REsearch and Care) aims to enable seamless, secure, scalable and consistent linkage of healthcare information, which resides in electronic health record (EHR) systems with information in clinical research information systems, such as clinical trials. Achieving semantic inter ...
Voir le projet
20
Participants partenaires
TERMINÉ
Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer (RESPONSIFY)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2015,
Individualisation of cancer therapy based on standardized biomarker assays is one of the most demanding challenges in cancer medicine. In the RESPONSIFY consortium, we will integrate information on response prediction from different breast cancer types and methodologies into biomarker tests for targeted therapies in the clinical routine setting. Those tests will be developed for commercialisation ...
Voir le projet
14
Participants partenaires
TERMINÉ
Driving Excellence in Integrative Cancer Research through Innovative Biomedical Infrastructures (INTEGRATE)
Date du début: 1 févr. 2011, Date de fin: 31 oct. 2014,
There is a strong need in biomedical research, especially in the case of complex heterogeneous diseases such as cancer, to achieve an all-comprising harmonization of efforts: To integrate the available data and knowledge in comprehensive models supported by interoperable infrastructures and tools, to standardize methodologies, and to achieve wide-scale data sharing and reuse, and multidisciplinary ...
Voir le projet
7
Participants partenaires
TERMINÉ
Identification and validation of new breast cancer biomarkers based on integrated metabolomics (METAcancer)
Date du début: 1 avr. 2008, Date de fin: 31 mars 2011,
Breast cancer is the most common cancer in women. It is therefore in the focus of approaches for the identification of predictive molecular biomarkers. In contrast to transcriptomics, the changes in metabolite levels that are associated with tumor development and progression have not been investigated to a great extent, so far. Metabolomics is defined as the study of all metabolites in a cell, ti ...
Voir le projet